Zhejiang Xianju Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZHEJIANG XIANJU, and what generic and branded alternatives to ZHEJIANG XIANJU drugs are available?
ZHEJIANG XIANJU has one approved drug.
Drugs and US Patents for Zhejiang Xianju
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zhejiang Xianju | PREDNISOLONE | prednisolone | TABLET;ORAL | 218083-001 | May 2, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.